Chat with us, powered by LiveChat


Medical Polymer Market Report


Medical Polymer Market by Product (Fibers & Resins, Biodegradable Polymers, Medical Elastomers, and Others), Application (Medical Device Packaging, Medical Components, Wound Care, Orthopedic Soft Goods, Cleanroom Supplies, Sterilization & Infection Prevention, BioPharm Devices, Denture-based Materials, Mobility Aids, Tooth Implants, and Other Implants), and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032


Pages: 310

Oct 2023

Medical Polymer Overview

Medical polymers are a type of materials utilised in numerous medical applications. These polymers are specially created and prepared to satisfy the exacting standards of the medical and healthcare sectors, including biocompatibility, sterilizability, and mechanical qualities suitable for certain applications. Medical polymers are also known as biomedical polymers or biopolymers. Medical polymer is widely used in healthcare sector.  These polymers are safe and efficient for use in a variety of medical applications. Medical polymers offer a wide range of properties and functionalities that make them suitable for diverse medical devices, drug delivery systems, tissue engineering, and other healthcare applications. Medical polymer fibres have a strong weight-to-strength ratio, which makes them the perfect material for many minimally invasive devices and medical apparel.

Global Medical Polymer Market Analysis

The global medical polymer market size was $20.2 billion in 2022 and is predicted to grow at a CAGR of 8.2%, by generating a revenue of $44.2 billion by 2032.

COVID-19 Impact on Global Medical Polymer Market

The medical polymer market has been positively affected by the Covid-19 pandemic. Personal protective equipment (PPE) like masks, gloves, gowns, and face shields saw a spike in demand as a result of the epidemic. During the pandemic, several businesses in the plastics sector changed the priority of their production lines to the production of medical supplies and equipment. To fulfil the rising demand, medical polymer production had to be boosted.

As healthcare systems continue to prioritise patient care and deal with the backlog of scheduled procedures, the demand for medical equipment is anticipated to increase. Implants, surgical instruments, diagnostic equipment, and wearable gadgets are just a few of the medical devices that must be made with medical polymers.

Increasing Demand for Medical Devices to Drive the Market Growth

The demand for medical devices has increased as a result of the growing prevalence of chronic diseases and age-related ailments around the world. The production of devices like implants, catheters, surgical instruments, drug delivery systems, and diagnostic tools requires the use of medical polymers. The demand for specialised medical devices and materials has increased because of technological developments in healthcare such as minimally invasive operations, robotic-assisted procedures, and personalised medicine. These technologies are greatly facilitated by medical polymers, which have special qualities like biocompatibility, flexibility, and strength. In healthcare settings, infection control is a major challenge. To reduce the risk of healthcare-associated infections, medical polymers with antibacterial properties and those that can be quickly sterilised are highly sought-after. These supplies improve patient safety and sterility in the workplace.

Stringent Regulatory Requirements to Restrain Market Growth

To protect the security and effectiveness of medical tools and supplies, the industry is subject to strict regulatory norms. Due to the complexity and length of the compliance procedure, medical polymers' product development and market launch may be delayed. New medical polymer development and commercialization come at a significant cost to research and development. The costs involved with introducing new medical polymers to the market can rise dramatically because of the requirement for rigorous testing, clinical trials, and regulatory compliance. Some businesses, particularly startups or smaller manufacturers, may be discouraged by these high expenses.

Advancements in Bioresorbable Polymers to Drive Excellent Opportunities

Bioresorbable polymers don't require surgery to be removed because they break down and are absorbed by the body over time. Applications for these polymers include tissue engineering, medication delivery systems, and sutures. The usage of bioresorbable polymers in medical applications will increase with continued research and development work to improve their biocompatibility, mechanical characteristics, and degradation rates. The fabrication of implants and medical devices could be revolutionised by 3D printing, often known as additive manufacturing. Medical polymers can be utilised to make intricate, patient-specific structures with exact geometry using printable materials. Through 3D printing, it is now possible to personalise medical devices, creating better patient outcomes and opening the door to personalised medicine.

Global Medical Polymer Market Share, by Product, 2022

The fibers & resins sub-segment accounted for the highest share in 2022. Medical polymers that employ fibres and resins offer lightweight solutions with exceptional strength and durability. These materials are employed in the production of medical implants, components, and devices when mechanical performance and weight reduction are essential for patient comfort and device functionality. For medical applications, fibres and resins with great biocompatibility are crucial. Biocompatible materials guarantee minimum negative reactions and allow the fusion of implants and medical equipment with the body's tissues. Furthermore, the creation of bioresorbable fibres and resins enables the use of transient implants that dissolve over time, negating the requirement for surgical removal.

Global Medical Polymer Market Share, by Application, 2022

The medical components sector accounted for the highest market size in 2022. Due to its benefits over conventional open surgeries, minimally invasive procedures including laparoscopic surgeries and endoscopic examinations are becoming more popular. By offering flexibility, manoeuvrability, and biocompatibility, medical components composed of polymers, such as catheters, guidewires, and cannulas, are crucial in enabling these treatments. Sophisticated medical components that can communicate with robotic systems are needed for improvements in surgical approaches, such as robotic-assisted surgeries. Polymers are ideal for robotic surgical instruments and components because they provide benefits including lightweight design, low friction, and electrical insulation.

Global Medical Polymer Market Share, by Region, 2022

The North America medical polymer market accounted for the highest market share in 2022. One of the world's biggest markets for medical polymers is found in North America. A growing need for cutting-edge medical equipment, an ageing population, and constant technological breakthroughs are some of the reasons that are driving the market in the region. The market size is anticipated to keep expanding as a result of the rising incidence of chronic diseases, improvements in the healthcare system, and the creation of new medical applications. Medical device and polymer production is well-established in North America. Many well-known manufacturers of medical polymers, including thermoplastics, thermosets, elastomers, and fibres, as well as producers of medical devices are based in the area. New medical polymer products are developed as a result of the presence of superior production technology and research facilities.

Competitive Scenario in the Global Medical Polymer Market

Product development and geographic expansion are the major strategies adopted by the leading players in the highly competitive global medical polymer market.

Some of the leading medical polymer market players are BASF SE, NatureWorks LLC, Exxon Mobil Corporation, Covestro AG, Dow Inc., Celanese Corporation, Eastman Chemical Corporation, Koninklijke DSM NV, Evonik Industries AG, and Arkema



Historical Market Estimations


Base Year for Market Estimation


Forecast Timeline for Market Projection


Geographical Scope

North America, Europe, Asia-Pacific, and LAMEA

Segmentation by Product

  • Fibers & Resins
  • Biodegradable Polymers
  • Medical Elastomers
  • Others

Segmentation by Application

  • Medical Device Packaging
  • Medical Components
  • Wound Care
  • Orthopedic Soft Goods
  • Cleanroom Supplies
  • Sterilization & Infection Prevention
  • BioPharm Devices
  • Denture-based Materials
  • Mobility Aids
  • Tooth Implants
  • Other Implants

Key Companies Profiled

  • NatureWorks LLC
  • Exxon Mobil Corporation
  • Covestro AG
  • Dow Inc.
  • Celanese Corporation
  • Eastman Chemical Corporation
  • Koninklijke DSM NV
  • Evonik Industries AG
  • Arkema


Frequently Asked Questions

A. The size of the medical polymer market was over $20.2 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.2% during the forecast period.

A. Eastman Chemical Corporation and Exxon Mobil Corporation are some of the key players in the global medical polymer market.

A. The Asia-Pacific region possesses great investment opportunities for investors to witness the most promising growth in the future.

A. Product development and geographic expansion are the two key strategies opted by the operating companies in this market.

A. Eastman Chemical Corporation and Exxon Mobil Corporation are the companies investing more in R&D activities for developing new products and technologies.

Purchase Options

Personalize this research

  • Triangulate with your own data
  • Request your format and definition
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

Customers Also Viewed